ARTICLE SUMMARY:
Clearly, hospitals have been targeting implant companies for a long time, with pricing declines by now ingrained in the industry. Will CMS’ new mandatory bundled payment scheme for total joint replacement surgery enable hospitals to gain even greater concessions or can industry push back?
The Centers for Medicare and Medicaid Services’ (CMS) aggressive plan to launch the first mandatory risk-sharing payment program for hip and knee replacement procedures in 67 cities signals just how intent the agency is on shifting the US fee-for-service reimbursement system to one that is based much more on pay for performance.
